Haematuria in Postrenal Transplant Patients

Table 2

Oncological outcomes of prostate cancer patients.

Comparison	Polcari et al., J Urol, USA, 2009 [76]	Antonopoulos et al., J Urol, Brazil, 2008 [77]	Kleinclauss et al., J Urol, France, 2008 [78]	Mouzin et al., Transplantation, France, 2004 [79]	Elkentaoui et al., J Urol, France, 2010 [80]	Detti et al., JJ Clinical Onco, Italy, 2011 [81]
	7	8	20	8	15	1
Clinical stage	pT1c-T2a	pT2a-T2c	pT2a-T3b	pT1c-T3a	pT2a-T3a	pT3b
Treatment	Robot-assisted radical prostatectomy	Radical prostatectomy	Radical prostatectomy	Three-dimensional conformal radiotherapy	Radical prostatectomy	Radical prostatectomy + adjuvant RT
Mean operative duration (min)	186	183	163	—	—	—
Mean blood loss (mL)	—	656	516	—	—	—
Mean hospital stay (days)	1.8	3	11.9	—	—	—
Postprocedure complications	42.9%	0	0	5/8 grades 1-2 cystitis	2/15 rectal injuries	Grade 1 cystitis
Mean follow-up (months)	16	10.5	23	28	26	—
Recurrence rate	1/7	0	2/20	2/8	1/15	0/1
Positive margins	2/7	2/8	2/20	—	0/15	1/1